Natural immunity to SARS-CoV-2 and breakthrough infections in vaccinated and unvaccinated patients with cancer

BACKGROUND: Consolidated evidence suggests spontaneous immunity from SARS-CoV-2 is not durable, leading to the risk of reinfection, especially in the context of newly emerging viral strains. In patients with cancer who survive COVID-19 prevalence and severity of SARS-CoV-2 reinfections are unknown....

Descripción completa

Detalles Bibliográficos
Autores principales: Cortellini, Alessio, Aguilar-Company, Juan, Salazar, Ramon, Bower, Mark, Sita-Lumsden, Ailsa, Plaja, Andrea, Lee, Alvin J. X., Bertuzzi, Alexia, Tondini, Carlo, Diamantis, Nikolaos, Martinez-Vila, Clara, Prat, Aleix, Apthorp, Eleanor, Gennari, Alessandra, Pinato, David J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9395853/
https://www.ncbi.nlm.nih.gov/pubmed/35995934
http://dx.doi.org/10.1038/s41416-022-01952-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9395853/
https://www.ncbi.nlm.nih.gov/pubmed/35995934
http://dx.doi.org/10.1038/s41416-022-01952-x

Ejemplares similares